To Evaluate the Effectiveness of Intralesional Alefacept Administration as Defined by the Psoriasis Severity Assessment Score Followed by the Evaluation of the Effectiveness of Intramuscular Alefacept Administration.
Number of Patients Who Were Both Intralesional and Intramuscular Responders.
18 Years and older (Adult, Senior)
May 15, 2008
February 22, 2013
February 15, 2013
UCSF Psoriasis and Skin Treatment Center San Francisco, California, United States
† Study has passed its completion date and status has not been verified in more than two years.